Experienced in Restrictive Cardiomyopathy (RCM)

Chang-wook M. Nam

Daegu, KR 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Restrictive Cardiomyopathy (RCM)
Daegu, KR 
OverviewLocationsClinical Research

Overview

Chang-wook Nam practices in Daegu, Republic of Korea. Nam is rated as an Experienced expert by MediFind in the treatment of Restrictive Cardiomyopathy (RCM). Their top areas of expertise are Coronary Heart Disease, Heart Attack, Stable Angina, Percutaneous Coronary Intervention (PCI), and Stent Placement.

Their clinical research consists of co-authoring 302 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Restrictive Cardiomyopathy (RCM).

Locations

Daegu, Republic of Korea
Other Locations
Uijeongbu St. Mary's Hospital, Incheon St. Mary's Hospital, Yangsan, Republic of Korea
Goyang, Republic of Korea
Sindang, Republic of Korea
Ulsan, Republic of Korea
Seoul, 110744, Republic of Korea
Gyeongju, Republic of Korea
Daejeon, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Multicenter, Prospective Cohort to Evaluate the Natural History of FFR Guided Percutaneous Coronary Intervention
A Multicenter, Prospective Cohort to Evaluate the Natural History of FFR Guided Percutaneous Coronary Intervention
Enrollment Status: Recruiting
Publish Date: November 14, 2024
IMaging and Physiologic Predictors of Atherosclerotic Progression in Deferred Lesions With Contemporary Medical Treatment Based on Fractional Flow Reserve-guided Strategy
IMaging and Physiologic Predictors of Atherosclerotic Progression in Deferred Lesions With Contemporary Medical Treatment Based on Fractional Flow Reserve-guided Strategy
Enrollment Status: Active_not_recruiting
Publish Date: May 15, 2025
Intervention Type: Device
Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events: BVS-LATE Trial
Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events: BVS-LATE Trial
Enrollment Status: Completed
Publish Date: June 25, 2024
Intervention Type: Drug
Study Phase: Phase 4
Multicenter Registry for Diagnostic Accuracy of Angiography-Derived Quantitative Flow Ratio to Evaluate the Hemodynamic Significance of Coronary Artery Stenosis
Multicenter Registry for Diagnostic Accuracy of Angiography-Derived Quantitative Flow Ratio to Evaluate the Hemodynamic Significance of Coronary Artery Stenosis
Enrollment Status: Completed
Publish Date: April 17, 2024
Intervention Type: Diagnostic test
Evaluation of Effectiveness and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease; A Multicenter, Prospective, Observational Registry Study
Evaluation of Effectiveness and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease; A Multicenter, Prospective, Observational Registry Study
Enrollment Status: Completed
Publish Date: February 06, 2024
Intervention Type: Device
Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Enrollment Status: Terminated
Publish Date: December 20, 2023
Intervention Type: Device
a Multinational, Multicenter, Prospective, Open-label, Active-treatment-controlled Randomized Trial: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque_PREVENT Trial
a Multinational, Multicenter, Prospective, Open-label, Active-treatment-controlled Randomized Trial: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque_PREVENT Trial
Enrollment Status: Completed
Publish Date: November 18, 2023
Intervention Type: Device, Drug
Study Drug: Optimal Medical treatment
Study Phase: Phase 4
Influence of Fractional Flow Reserve (FFR) on the Clinical OutcomEs of PERcutaneouS Coronary Intervention (PCI): A ProspECTIVE, Multicenter FFR Registry
Influence of Fractional Flow Reserve (FFR) on the Clinical OutcomEs of PERcutaneouS Coronary Intervention (PCI): A ProspECTIVE, Multicenter FFR Registry
Enrollment Status: Completed
Publish Date: September 28, 2023
Phase 3 Study of Effect of ATorvastatin on Fractional Flow Reserve in Coronary Artery Disease
Phase 3 Study of Effect of ATorvastatin on Fractional Flow Reserve in Coronary Artery Disease
Enrollment Status: Completed
Publish Date: April 12, 2023
Intervention Type: Drug
Study Phase: Phase 3
Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation : STAMP-DES Trial
Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation : STAMP-DES Trial
Enrollment Status: Terminated
Publish Date: February 23, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 9 Less Clinical Trials

302 Total Publications

Clinical Relevance of Fractional Flow Reserve-Guided Percutaneous Coronary Interevention According to Left Ventricular Ejection Fraction in Patients With Acute Myocardial Infarction and Multivessel Disease.
Clinical Relevance of Fractional Flow Reserve-Guided Percutaneous Coronary Interevention According to Left Ventricular Ejection Fraction in Patients With Acute Myocardial Infarction and Multivessel Disease.
Journal: Journal of the American Heart Association
Published: August 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Nam's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile